La Banque Postale Asset Management Sa Biogen Inc. Transaction History

La Banque Postale Asset Management Sa

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $261,152 - $294,752	1,031 Added 17.89%	6,795 $1.75 Billion
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $720,604 - $832,681	-2,618 Reduced 31.23%	5,764 $1.64 Billion
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $348,665 - $397,290	1,359 Added 19.35%	8,382 $2.33 Billion
Q4 2022 May 15, 2023	BUY	$252.44 - $306.72 $1.77 Million - $2.15 Million	7,023 New	7,023 $1.94 Billion

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of La Banque Postale Asset Management Sa, based on Form 13F filings with the SEC.

Stay updated on La Banque Postale Asset Management Sa with notifications on news.